• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异克舒令治疗原发性痛经及其对经前紧张症的疗效。

Isoxsuprine in primary dysmenorrhoea. Its effectiveness in premenstrual tension.

作者信息

Gallegos-Torres J, Flores-Mercado F

机构信息

Centro Gineco-Pediatrico Privado, Sinaloa, Mexico.

出版信息

J Int Med Res. 1975;3(3):194-201. doi: 10.1177/030006057500300309.

DOI:10.1177/030006057500300309
PMID:162675
Abstract

The drug combination including isoxsuprine 10 mg, acetaminophen 250 mg and caffeine 30 mg was administered to 80 patients divided into two groups, 40 with premenstrual tension and 40 with clinically diagnosed primary dysmenorrhoea. The study was carried out by the double-blind method and the patients were distributed at random. The results obtained show an excellent or very good response in 95% of cases of premenstrual tension and in 92.5% of cases of dysmenorrhoea. When the overall effectiveness of the compound in both conditions is considered, we find it to be 93.75%. A general discussion of the findings is presented in relation to age, civil status, time of appearance of dysmenorrhoea, nature of pain, accompanying symptoms, previous treatment, other non-drug therapies, results obtained, time within which symptoms were alleviated, total dose of the drug and side-effects. It is concluded that the orally-administered therapeutic combination is effective in both dysmenorrhoea and premenstrual tension.

摘要

将含有10毫克异克舒令、250毫克对乙酰氨基酚和30毫克咖啡因的药物组合给予80名患者,这些患者被分为两组,40名患有经前紧张症,40名患有临床诊断的原发性痛经。该研究采用双盲法进行,患者随机分配。所得结果显示,95%的经前紧张症病例和92.5%的痛经病例有极佳或非常好的反应。当考虑该化合物在两种病症中的总体有效性时,我们发现其为93.75%。针对年龄、婚姻状况、痛经出现时间、疼痛性质、伴随症状、既往治疗、其他非药物疗法、所得结果、症状缓解时间、药物总剂量和副作用等方面,对研究结果进行了全面讨论。得出的结论是,口服治疗组合对痛经和经前紧张症均有效。

相似文献

1
Isoxsuprine in primary dysmenorrhoea. Its effectiveness in premenstrual tension.异克舒令治疗原发性痛经及其对经前紧张症的疗效。
J Int Med Res. 1975;3(3):194-201. doi: 10.1177/030006057500300309.
2
[Isoxsuprine in primary dysmenorrhea. Its efficiency in premenstrual tension].[异克舒令治疗原发性痛经。其对经前紧张症的疗效]
Ginecol Obstet Mex. 1975 Oct;38(228):279-87.
3
Beta2-adrenoceptor agonists for dysmenorrhoea.用于痛经的β2肾上腺素能受体激动剂。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008585. doi: 10.1002/14651858.CD008585.pub2.
4
Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea.
Curr Med Res Opin. 2007 Apr;23(4):841-51. doi: 10.1185/030079907x182239.
5
[Primary dysmenorrhoea and hyperprolactinemia (author's transl)].
Geburtshilfe Frauenheilkd. 1978 Jul;38(7):569-72.
6
[Gynecologic-obstetric pain therapy. Use of Lonarid N].[妇产科疼痛治疗。洛那利德N的应用]
ZFA (Stuttgart). 1980 Feb 20;56(5):359-62.
7
Relief of pain in primary dysmenorrhoea by beta-adrenoceptor stimulating drugs.β-肾上腺素能受体激动剂缓解原发性痛经的疼痛
Acta Obstet Gynecol Scand. 1977;56(3):255-6.
8
A double-blind randomized study of an aspirin/caffeine combination versus acetaminophen/aspirin combination versus acetaminophen versus placebo in patients with moderate to severe post-partum pain.一项针对中度至重度产后疼痛患者,比较阿司匹林/咖啡因组合、对乙酰氨基酚/阿司匹林组合、对乙酰氨基酚与安慰剂的双盲随机研究。
J Int Med Res. 1984;12(6):338-45. doi: 10.1177/030006058401200604.
9
Study of a new analgesic compound in the treatment of tension headache.一种新型镇痛化合物治疗紧张性头痛的研究。
J Int Med Res. 1976;4(1):74-8. doi: 10.1177/030006057600400112.
10
Dysmenorrhea and pre-menstrual tension in adolescents.
IMJ Ill Med J. 1967 Feb;131(2):184-6.

引用本文的文献

1
A preliminary pilot randomized crossover study of uzara (Xysmalobium undulatum) versus ibuprofen in the treatment of primary dysmenorrhea.一项关于乌扎拉(波叶金雀花)与布洛芬治疗原发性痛经的初步试点随机交叉研究。
PLoS One. 2014 Aug 13;9(8):e104473. doi: 10.1371/journal.pone.0104473. eCollection 2014.
2
Beta2-adrenoceptor agonists for dysmenorrhoea.用于痛经的β2肾上腺素能受体激动剂。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008585. doi: 10.1002/14651858.CD008585.pub2.